Abbott India reports 54% rise in Q1 net profit

Abbott India Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 500488 | NSE: ABBOTINDIA

10 Aug 2020 Evaluate

Abbott India has reported results for first quarter ended June 30, 2020.

The company has reported 54.22% rise in its net profit at Rs 180.35 crore for the quarter under review as compared to Rs 116.94 crore for the same quarter in the previous year. Total income of the company increased by 6.17% at Rs 1,091.90 crore for Q1FY21 as compared Rs 1,028.49 crore for the corresponding quarter previous year.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Peers

Company Name	CMP
Sun Pharma. Inds.	1853.50
Dr. Reddys Labs.	1202.80
Cipla	1397.20
Lupin	2090.00
Zydus Lifesciences	1202.00
View more..

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.